Pharmaceutical

FDA approves AbbVie’s VYALEV for advanced Parkinson’s treatment

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).

Oct 20, 2024 - 04:00
FDA approves AbbVie’s VYALEV for advanced Parkinson’s treatment
The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).
Read the original article

Tags:

Previous Article

US Elections: how healthcare could look under a Harris or Trump administration

Next Article

Cambridge University and GSK sign immunology R&D collaboration

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk adjusted net present value: What is the current va...

Dec 15, 2024

Opinion: A program to bring internet access to low-income people is running out of money. Health care will suffer

Opinion: A program to bring internet access to low-inco...

Jul 20, 2023

Kronos mulls ‘strategic alternatives’ after axing cancer drug development

Kronos mulls ‘strategic alternatives’ after axing cance...

Nov 15, 2024